Antibiotic Resistant Gram-negative bacteria
Testing directly from:
|
|
|
|
Nasal, throat, rectal, wound, vaginal and urethral swabs |
Bacterial culture on agar plates |
Grown 'positive' blood culture liquid media |
Urine sample |
WHO has declared that AMR is one of the top 10 global public health threats facing humanity. The misuse and overuse of antimicrobials are the main drivers in the development of drug resistant pathogens.
TIME FOR CHANGE!
The eazyplex® SuperBug series is a direct response to these challenges! The eazyplex® tests are easy-to-use and user-friendly molecular tests that detects resistance genes in under 30 minutes directly from sample material.
These rapid diagnostic tests cover both prevalent Gram negative resistances (such as KPC, NDM, and CTX-M) and the less prevalent yet equally important resistance genes like GIM, GES, and AmpC. The simplicity and efficiency of our tests make them almost as convenient as Point-of-Care Testing (POCT), revolutionising the way antimicrobial resistance is managed in clinical settings.
TIME FOR CHANGE!
The eazyplex® SuperBug series is a direct response to these challenges! The eazyplex® tests are easy-to-use and user-friendly molecular tests that detects resistance genes in under 30 minutes directly from sample material.
These rapid diagnostic tests cover both prevalent Gram negative resistances (such as KPC, NDM, and CTX-M) and the less prevalent yet equally important resistance genes like GIM, GES, and AmpC. The simplicity and efficiency of our tests make them almost as convenient as Point-of-Care Testing (POCT), revolutionising the way antimicrobial resistance is managed in clinical settings.
|
The eazyplex® SuperBug series
The eazyplex® SuperBug series is a molecular identification product based on LAMP technology. Key characteristics are:
|
This column illustrates the development of eazyplex® SuperBug over the last decade.
These publications of eazyplex®SuperBug series and the other eazyplex® panels can be accessed here
Acinetobacter
|
This eazyplex® SuperBug product line
Many parameters are available in the eazyplex® SuperBug series.
Hands-on-time approx. 3 min.
All signals are displayed in real time during the amplification.
The eazyplex® test system is a lyophilised, ready-to-use amplification system and can be stored directly at the workplace at room temperature.
Many parameters are available in the eazyplex® SuperBug series.
Hands-on-time approx. 3 min.
- First signals in less than 10 min.
- Complete test run finished in 20 min.
- Results output as PDF, CSV and adhesive label
All signals are displayed in real time during the amplification.
The eazyplex® test system is a lyophilised, ready-to-use amplification system and can be stored directly at the workplace at room temperature.
The eazyplex® panels line offers much more
Introducing Amplex eazyplex® LAMP assays to your hospital opens the door to a wide range of molecular diagnostics.
For example in under 30 minutes the eazyplex®Blood Screen will provide first steps in your septicaemia case. The range of assays include others that all require urgent action such as meningitis, STIs, ARMs, Candida auris etc.
Introducing Amplex eazyplex® LAMP assays to your hospital opens the door to a wide range of molecular diagnostics.
For example in under 30 minutes the eazyplex®Blood Screen will provide first steps in your septicaemia case. The range of assays include others that all require urgent action such as meningitis, STIs, ARMs, Candida auris etc.
eazyplex® panels publications
The eazyplex® panels publications library includes over 25 publications from 9 European countries.
The eazyplex® panels publications library includes over 25 publications from 9 European countries.
To access the eazyplex® panels publications library - click on the graphic above.
The products covered are relevant to acute infectious diseases such as septicaemia, pneumonia, and meningitis, also covered are specific key pathogens such as C. auris, MRSA, C. difficile, Salmonella typhi, SARs-CoV-2, Pneumocystis jirovecii and EHEC.
Resistance to antibiotics in pathogens is widely covered, particularly in Gram-negatives. The eazyplex® SuperBug series not only cover the common resistances such as KPC, NDM, AmpC and CTX-M, but cover resistance genes, such as GIM and GES which are still rare at the moment. The Blood Screen panel not only detects the most common bacterial pathogens of sepsis but also associated CTX-M-1 and CTX -M-9 genes.
Acinetobacter: Multi-drug-resistant Acinetobacter baumannii is considered a major public-health threat owing to limited treatment options. Results of a published evaluation show that the eazyplex® SuperBug Acineto test is a rapid (15–30 min) and reliable test for the detection of the most common carbapenemases observed in Acinetobacter spp. and for species determination of A. baumannii.
The products covered are relevant to acute infectious diseases such as septicaemia, pneumonia, and meningitis, also covered are specific key pathogens such as C. auris, MRSA, C. difficile, Salmonella typhi, SARs-CoV-2, Pneumocystis jirovecii and EHEC.
Resistance to antibiotics in pathogens is widely covered, particularly in Gram-negatives. The eazyplex® SuperBug series not only cover the common resistances such as KPC, NDM, AmpC and CTX-M, but cover resistance genes, such as GIM and GES which are still rare at the moment. The Blood Screen panel not only detects the most common bacterial pathogens of sepsis but also associated CTX-M-1 and CTX -M-9 genes.
Acinetobacter: Multi-drug-resistant Acinetobacter baumannii is considered a major public-health threat owing to limited treatment options. Results of a published evaluation show that the eazyplex® SuperBug Acineto test is a rapid (15–30 min) and reliable test for the detection of the most common carbapenemases observed in Acinetobacter spp. and for species determination of A. baumannii.
The Genie® Molecular Diagnostics Platforms
The Genie® is a revolutionary processing device designed for fast and highly sensitive molecular diagnostics of DNA and RNA. Powered by isothermal amplification technology, this platform offers unparalleled flexibility and performance.
Key Features:
The Genie® is a revolutionary processing device designed for fast and highly sensitive molecular diagnostics of DNA and RNA. Powered by isothermal amplification technology, this platform offers unparalleled flexibility and performance.
Key Features:
- Genie® II: The compact and robust Genie® II is ideal for rapid individual tests, operating 24/7. With two independently controlled heating blocks, it offers maximum flexibility and efficiency in testing.
- Genie® HT: The Genie® HT is a modular upgrade designed for high-throughput settings. Featuring 1 to 12 independent working blocks, it enables seamless scalability and increased throughput for large-scale testing requirements.
